Search All Tech Briefings

Search technology briefings produced by NIHR Innovation Observatory. These are short reports on new or repurposed medicines that we have already sent to our stakeholders. Only those technologies (medicines) that are within the scope of our stakeholders will have a technology briefing available. Search our technology briefings by intervention (drug or device), specific indication (disease or condition), or general therapeutic area.

| 157 Results

Clear All Filters

Title	Intervention	Indication	Therapeutic Area	Year	Actions
Carfilzomib in addition to daratumumab and dexamethasone for relapsed and/or refractory multiple myeloma	Carfilzomib (Kyprolis; ONO-7057) , Daratumumab (Darzalex; JNJ-54767414) , Dexamethasone (dexamethasone sodium metasulfobenzoate)	Multiple myeloma (MM)	Haematological Cancer and Lymphomas	2019	View \| Download
Cabozantinib with atezolizumab for treating metastatic castration-resistant prostate cancer after one novel hormonal therapy	Atezolizumab (Tecentriq; MPDL3280A) , Cabozantinib (XL-184; Cabometyx; Cometriq; XL 184)	Prostate cancer	Haematological Cancer and Lymphomas , Oncology	2023	View \| Download
Brentuximab vedotin with doxorubicin, dacarbazine and vinblastine for previously untreated late-stage classical Hodgkin lymphoma	Brentuximab vedotin (Adcetris; SGN-35) , Dacarbazine (dacarbazine citrate) , Doxorubicin (Livatag; BA-003; Caelyx; Sarcodoxome; SP-1049C; Resmycin; JNS002; doxorubicin hydrochloride) , Vinblastine (vinblastine sulfate)	Hodgkin lymphoma	Haematological Cancer and Lymphomas	2023	View \| Download
Brentuximab vedotin with cyclophosphamide, prednisone and doxorubicin for treating peripheral Tcell lymphoma	Brentuximab vedotin (Adcetris; SGN-35) , Cyclophosphamide (Procytox; cyclophosphamide monohydrate) , Doxorubicin (Livatag; BA-003; Caelyx; Sarcodoxome; SP-1049C; Resmycin; JNS002; doxorubicin hydrochloride) , Prednisone (Decadron; Lodotra)	Peripheral T-cell lymphoma (PTCL)	Haematological Cancer and Lymphomas	2024	View \| Download
Brentuximab vedotin with chemotherapy (BrECADD) for previously untreated advanced classical Hodgkin lymphoma	Brentuximab vedotin (Adcetris; SGN-35) , Chemotherapy	Hodgkin lymphoma	Haematological Cancer and Lymphomas	2024	View \| Download
Brentuximab vedotin in addition to cyclophosphamide, doxorubicin, and prednisolone (CHP) for CD30+ mature T-cell lymphoma	Brentuximab vedotin (Adcetris; SGN-35) , CHP	Mature T-cell lymphoma	Haematological Cancer and Lymphomas	2018	View \| Download
Brentuximab vedotin (Adcetris) for treatment naive Hodgkin’s Lymphoma	Adriamycin , Brentuximab vedotin (Adcetris; SGN-35) , Dacarbazine (dacarbazine citrate) , Vinblastine (vinblastine sulfate)	Hodgkin lymphoma	Haematological Cancer and Lymphomas	2017	View \| Download
Bosutinib (Bosulif) for Philadelphia positive chronic myeloid leukaemia – first line	Bosutinib (Bosulif; PF-05208763; bosutinib monohydrate)	Chronic myeloid leukaemia (CML)	Haematological Cancer and Lymphomas	2017	View \| Download
Blinatumomab with chemotherapy for frontline consolidation treatment of Philadelphia chromosome negative, measurable residual disease negative, B-lineage acute lymphoblastic leukaemia	Blinatumomab (Blincyto) , Chemotherapy	Acute lymphoblastic leukaemia (ALL)	Haematological Cancer and Lymphomas	2024	View \| Download
Blinatumomab (Blincyto) for First Relapsed/Refractory, B-precursor, Acute Lymphoblastic Leukaemia, in Children and Adolescents	Blinatumomab (Blincyto)	Acute lymphoblastic leukaemia (ALL)	Haematological Cancer and Lymphomas	2017	View \| Download